Can anticyclic citrullinated peptide antibodies be used to successfully monitor treatment in rheumatoid arthritis patients?
Vallbracht
L L
LL
D000974:Antibodies, Antinuclear / Q000097:blood; D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D015415:Biomarkers / Q000097:blood; D018450:Disease Progression; D006801:Humans; D010456:Peptides, Cyclic / Q000276:immunology*
D000974:Antibodies, Antinuclear; D015415:Biomarkers; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide